Background Plasma biomarkers reflecting the pathology of frontotemporal dementia would add significant value to clinical practice, to the design and implementation of treatment trials as well as our understanding of disease mechanisms. The aim of this study was to explore the levels of multiple plasma proteins in individuals from families with genetic frontotemporal dementia.Methods Blood samples from 693 participants in the GENetic Frontotemporal Dementia Initiative study were analysed using a multiplexed antibody array targeting 158 proteins.Results We found 13 elevated proteins in symptomatic mutation carriers, when comparing plasma levels from people diagnosed with genetic FTD to healthy non-mutation controls and 10 proteins that were elevated compared to presymptomatic mutation carriers.Conclusion We identified plasma proteins with altered levels in symptomatic mutation carriers compared to non-carrier controls as well as to presymptomatic mutation carriers. Further investigations are needed to elucidate their potential as fluid biomarkers of the disease process.
Altered plasma protein profiles in genetic FTD - a GENFI study / Abbe, Ullgren; Linn, Öijerstedt; Jennie, Olofsson; Sofia, Bergström; Julia, Remnestål; John C, van Swieten; Lize C, Jiskoot; Harro, Seelaar; Barbara, Borroni; Raquel, Sanchez-Valle; Fermin, Moreno; Robert, Laforce; Matthis, Synofzik; Daniela, Galimberti; James B, Rowe; Mario, Masellis; Maria Carmela, Tartaglia; Elizabeth, Finger; Rik, Vandenberghe; Alexandre, de Mendonça; Pietro, Tirabosch; Isabel, Santana; Simon, Ducharme; Chris R, Butler; Alexander, Gerhard; Markus, Otto; Arabella, Bouzigues; Lucy, Russell; Imogen J, Swift; Aitana, Sogorb-Esteve; Carolin, Heller; Jonathan D, Rohrer; Anna, Månberg; Peter, Nilsson; Caroline, Graff; Afonso, Sónia; Rosario Almeida, Maria; Anderl-Straub, Sarah; Andersson, Christin; Antonell, Anna; Arighi, Andrea; Balasa, Mircea; Barandiaran, Myriam; Bargalló, Nuria; Bartha, Robart; Bender, Benjamin; Buratti, Emanuele; Benussi, Luisa; Bertoux, Maxime; Binetti, Giuliano; Black, Sandra; Bocchetta, Martina; Borrego-Ecija, Sergi; Bras, Jose; Bruffaerts, Rose; Cañada, Marta; Cantoni, Valentina; Caroppo, Paola; Cash, David; Castelo-Branco, Miguel; Convery, Rhian; Cope, Thomas; Deramecourt, Vincent; Di Fede, Giuseppe; Díez, Alina; Fenoglio, Chiara; B Ferreira, Catarina; Fox, Nick; Freedman, Morris; Fumagalli, Giorgio; Funkiewiez, Aurélie; Gabilondo, Alazne; Gasparotti, Roberto; Gauthier, Serge; Alberici, Antonella; Giaccone, Giorgio; Gorostidi, Ana; Greaves, Caroline; Guerreiro, Rita; Indakoetxea, Begoña; Jelic, Vesna; Karnath, Hans-Otto; Keren, Ron; Kuchcinski, Gregory; Langheinrich, Tobias; Lebouvier, Thibaud; João Leitão, Maria; Lladó, Albert; Maruta, Carolina; Meeter, Lieke; Miltenberger, Gabriel; van Minkelen, Rick; Mitchell, Sara; Moore, Katrina; Nicholas, Jennifer; Olives, Jaume; Ourselin, Sebastien; Padovani, Alessandro; Panman, Jessica; M Papma, Janne; Peakman, Georgia; Pievani, Michela; Pijnenburg, Yolande; Premi, Enrico; Prioni, Sara; Rademakers, Rosa; Redaelli, Veronica; Rinaldi, Daisy; Rittman, Tim; Rogaeva, Ekaterina; Rollin, Adeline; Rosa-Neto, Pedro; Rossi, Giacomina; Rosser, Martin; Scarpini, Elio; Semler, Elisa; Shafei, Rachelle; Shoesmith, Christen; Tábuas-Pereira, Miguel; Tainta, Mikel; Taipa, Ricardo; Tang-Wai, David; L Thomas, David; Thompson, Paul; Thonberg, Håkan; Timberlake, Carolyn; Todd, Emily; Van Damme, Philip; Vandenbulcke, Mathieu; Veldsman, Michele; Verdelho, Ana; Villanua, Jorge; Warren, Jason; Wilke, Carlo; Woollacott, Ione; Zetterberg, Henrik; Zulaica, Miren; Durães, João; Lima, Marisa; Lemos, João. - In: MOLECULAR NEURODEGENERATION. - ISSN 1750-1326. - 18:1(2023), pp. 8501-8512. [10.1186/s13024-023-00677-6]
Altered plasma protein profiles in genetic FTD - a GENFI study
Giorgio Fumagalli;
2023-01-01
Abstract
Background Plasma biomarkers reflecting the pathology of frontotemporal dementia would add significant value to clinical practice, to the design and implementation of treatment trials as well as our understanding of disease mechanisms. The aim of this study was to explore the levels of multiple plasma proteins in individuals from families with genetic frontotemporal dementia.Methods Blood samples from 693 participants in the GENetic Frontotemporal Dementia Initiative study were analysed using a multiplexed antibody array targeting 158 proteins.Results We found 13 elevated proteins in symptomatic mutation carriers, when comparing plasma levels from people diagnosed with genetic FTD to healthy non-mutation controls and 10 proteins that were elevated compared to presymptomatic mutation carriers.Conclusion We identified plasma proteins with altered levels in symptomatic mutation carriers compared to non-carrier controls as well as to presymptomatic mutation carriers. Further investigations are needed to elucidate their potential as fluid biomarkers of the disease process.| File | Dimensione | Formato | |
|---|---|---|---|
|
2023 Ullgren et al MolNeurodegen.pdf
accesso aperto
Tipologia:
Versione editoriale (Publisher’s layout)
Licenza:
Creative commons
Dimensione
1.09 MB
Formato
Adobe PDF
|
1.09 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione
